axi-cel in older patients: data from zuma-1 and clinical use
Published 5 years ago • 53 plays • Length 2:59Download video MP4
Download video MP3
Similar videos
-
4:44
zuma-7 subgroup analysis: axi-cel vs soc in elderly patients with r/r lbcl
-
3:32
zuma-1: updated data and future prospects
-
1:41
zuma-1: 3-year follow-up on axi-cel in lbcl patients
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
2:55
updates from zuma-7: axi-cel for r/r dlbcl
-
25:30
hemolyzer 3 pro
-
3:02
daily check at christmas of linac ix varian medical system
-
17:02
sorin xtra cell saver setup and operation
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
2:06
car-t in dlbcl: 4-year follow-up data from zuma-1
-
0:54
zuma-3 end of phase i results: axi-cel for r/r all
-
2:32
zuma-1 update: durable survival in r/r dlbcl patients treated with axi-cel
-
2:19
zuma-3: identifying the optimal dose of axi-cel in r/r all
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
3:21
comparing the efficacy of tisa-cel and axi-cel in patients with r/r fl
-
2:06
zuma-12: axi-cel as first-line therapy in high-risk large b-cell lymphoma
-
2:24
zuma-1: a pivotal trial of axicabtagene ciloleucel (axi-cel; kte-c19) in patients with nhl
-
1:36
real-world comparison of axi-cel and tisa-cel in r/r dlbcl
-
1:45
matched comparison of tisa-cel and axi-cel in r/r dlbcl
-
4:03
axi-cel plus rituximab for r/r lbcl and updates from the zuma-14 study
-
3:59
real world data for axi-cel in lymphoma with secondary cns involvement
-
2:52
zuma-24 preliminary analysis of axi-cel in the outpatient setting in patients with r/r lbcl